Growth Equity

Titan Investors, a master of curated financial events, partners with Corridor Capital. Can private equity funding scale its exclusive model or will growth dilute it?

Private equity firm TowerBrook backs founder-led Rael, signaling a major investment in the booming holistic cycle care market. What does this mean for conscious consumerism?

LB Capital's planned $30M raise highlights the booming litigation finance market, a nexus of capital and justice that offers lifelines to plaintiffs.

A massive $250M funding round for orbital data centers signals a new space race, pitting tech giants against the physical limits of Earth's power grid.

A strategic investment in Emergent 3 signals a market shift from simple alerts to a new era of actionable intelligence for schools, hospitals, and government.

A new minority investment, advised by Cabrera Capital, positions engineering leader Cordoba to tackle California's critical infrastructure deficit.

A rebranding reveals a seismic shift in wealth management, where surging demand for attorney-led estate planning is fueling a new, tech-powered legal model.

A hometown private equity deal for Dumpsters.com isn't just about hauling trash. It's a blueprint for digitizing a massive, fragmented industry.

Once a rental site, ApartmentIQ now uses AI to manage 8M units. Its $25M funding signals a tech shift, raising questions about efficiency and affordability.

Vynca's spot on the Inc. 5000 isn't just a business win; it's a validation of a tech-driven, humane approach to serious illness care at scale.

Landing on the Inc. 5000 list four years running is impressive, but SavvyMoney's real achievement lies in building the B2B engine powering modern banking.

Ireland's H&MV Engineering secures a €1.4B valuation in a landmark deal. This is the story of how the global demand for AI and green energy is creating fortunes.

Lumilens emerges from stealth with $900M and a multi-billion dollar deal, betting that the future of AI isn't just compute, but the speed of light.

With $60M in new funding and veteran pharma execs on board, Vedanta Biosciences is set for the pivotal last leg of its Phase 3 trial for VE303.

With $20M in new capital, Ordway is doubling down on AI to automate the quote-to-cash mess. But can its profitable growth model redefine FinTech?

A strategic investment in Carolina Components Group signals a larger PE trend: fortifying the single-use technology supply chain to de-risk drug manufacturing.

With a 3.2 million worker shortage looming, a new investment in online trainer ACT reveals how private equity plans to scale a tech-driven solution.

With a major cash infusion, CND Life Sciences is set to scale its skin-based test for Parkinson's, signaling a shift from subjective diagnosis to objective data.

A seven-figure investment in a YouTube horror star signals a major shift. Is the next Hollywood mogul a digital creator with a built-in billion-view audience?

With a new $300M+ funding round, Xsight Labs is challenging giants like NVIDIA by championing open, programmable hardware for next-gen data centers.